ANCA ASSOCIATED SYSTEMIC VASCULITIS
Clinical trials for ANCA ASSOCIATED SYSTEMIC VASCULITIS explained in plain language.
Never miss a new study
Get alerted when new ANCA ASSOCIATED SYSTEMIC VASCULITIS trials appear
Sign up with your email to follow new studies for ANCA ASSOCIATED SYSTEMIC VASCULITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
One-Shot gene therapy tested to halt devastating autoimmune attacks
Disease control Recruiting nowThis early-stage study is testing a new, one-time treatment called TI-0032-III for people with severe autoimmune diseases like lupus and scleroderma that haven't improved with standard drugs. The treatment uses an injection to genetically reprogram the patient's own immune cells …
Matched conditions: ANCA ASSOCIATED SYSTEMIC VASCULITIS
Phase: PHASE1 • Sponsor: Therorna • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Off-the-Shelf cell therapy tested as potential reset for stubborn autoimmune diseases
Disease control Recruiting nowThis early-stage study is testing the safety and initial effects of a new type of cell therapy for people with severe autoimmune diseases that haven't responded well to standard treatments. The therapy, called 'universal' CAR-T, uses donated immune cells engineered to target and …
Matched conditions: ANCA ASSOCIATED SYSTEMIC VASCULITIS
Phase: PHASE1 • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC